WebFeb 14, 2014 · Most of in vitro kinetics of drugs released from nanoparticles under various conditions can be described by the K-P model. The K-P and the modified K-P models were investigated to identify the most appropriate model to describe the in vitro drug release kinetics for the selected nanoparticle formulations. The tested drug delivery system was ... http://www.nanomedicine-rj.com/article_22034_14b22354d48338e4f3bca2bf97f57bcc.pdf
Drug Release SpringerLink
WebMay 2, 2024 · Eight drug release models as well as the second degree polynomial modelwerecomparedinthisstudytofindoutwhetheranearlyuniversal model for describing … WebMay 5, 2014 · The drug release from the nanohybrids was sustained and the release rate of cetirizine from the nanohybrids at pH 7.4 was significantly slower than at pH 4.8 due to different release mechanisms. Furthermore, the release kinetics of cetirizine from the nanocomposites was fitted satisfactorily by pseudo-second order kinetics . chung horng enterprise co ltd
Kinetic modeling on drug release from controlled drug delivery systems
WebData Analysis: To analyze the in vitro release data various kinetic models were used to describe the release kinetics. The zero order rate Eq. (1) describes the systems where the drug release rate is independent of its concentration (12). The first order Eq. (2) describes the release from system where release rate is concentration dependent (13 ... WebApr 13, 2024 · Purpose To understand how surfactants affect drug release from ternary amorphous solid dispersions (ASDs), and to investigate different mechanisms of release enhancement. Methods Ternary ASDs containing ritonavir (RTV), polyvinylpyrrolidone/vinyl acetate (PVPVA) and a surfactant (sodium dodecyl sulfate (SDS), Tween 80, Span 20 or … WebThe drug release kinetics of generic products should be similar to the innovator product to have equivalent therapeutic efficacy. This study aims to evaluate the drug release … chunghop universal remote